Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CVKD stock hub

Cadrenal Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

CVKDis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
18.7M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
CVKD
In the news

Latest news · CVKD

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-300.6
P25 -105.6P50 -46.5P75 -3.1
ROIC-190.4
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All CVKD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
170
Groups with data
11
Currency
USD
Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

23
MetricValue
Cik
0001937993
Company name
Cadrenal Therapeutics, Inc.
Country
United States
Country code
US
Employees
4
Employees Change
1%
Employees Change Percent
33.33
Enterprise value
$16.4M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
IPO Date
2023-01-20
Isin
US1276362076
Last refreshed
2026-05-10
Market cap
$18.7M
Market cap category
Nano-Cap
Price
$6.09
Price currency
USD
Sector
Healthcare
Sic
2834
Symbol
CVKD
Website
https://www.cadrenal.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-63.42%
FCF yield
-58.45%
P/B ratio
8.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

8
MetricValue
Net Income
$-11.9M
Net Income Growth Quarters
2%
Net Income Growth Years
0%
Profit Per Employee
$-3M
ROA
-139.2
ROCE
-670.4
ROE
-300.6
ROIC
-190.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

5
MetricValue
Cagr1y
-62.61%
Cagr3y
-33.48%
EPS Growth Quarters
4
EPS Growth Years
3
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

15
MetricValue
Assets
$2.9M
Cash
$2.3M
Current Assets
$2.9M
Current Liabilities
$1.1M
Equity
$1.8M
Liabilities
$1.1M
Long Term Assets
$6,786
Long Term Liabilities
$0
Net Cash
$2.3M
Net Cash By Market Cap
$12.31
Net Cash Growth
-68.54%
Net Debt Equity
$-1.28
Tangible Book Value
$1.8M
Tangible Book Value Per Share
$0.72
WACC
14.32

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
2.68
Net Working Capital
$-517,808
Quick ratio
2.17
Working Capital
$1.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-50.99%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
-62.58%
200-day SMA
9.48
3Y total return
-70.58%
50-day SMA
6.14
50-day SMA vs 200-day SMA
50under200
All Time High
101.3
All Time High Change
-93.99%
All Time High Date
2023-01-20
All Time Low
4.21
All Time Low Change
44.66%
All Time Low Date
2026-03-30
ATR
0.68
Beta
1.83
Beta1y
2.02
Beta2y
1.05
Ch YTD
-10.18
High
6.49
High52
16.5
High52 Date
2025-05-08
High52ch
-63.09%
Low
5.84
Low52
4.21
Low52 Date
2026-03-30
Low52ch
44.66%
Ma50ch
-0.83%
Price vs 200-day SMA
-35.75%
RSI
53.62
RSI Monthly
36.19
RSI Weekly
41.13
Sharpe ratio
-0.54x
Sortino ratio
-0.74
Total Return
-50.99%
Tr YTD
-10.18
Tr1m
40.97%
Tr1w
-4.09%
Tr3m
6.84%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Analyst Count
1
Analyst Ratings
Strong Buy
Earnings EPS Estimate
$-1.56
Operating Income
$-12M
Price target
$13
Price Target Change
$113

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
2,555,214%
Float Percent
83.01%
Shares Insiders
16.99%
Shares Institutions
6.56%
Shares Out
3,078,247
Shares Qo Q
13.41%
Shares Yo Y
50.99%
Short Float
1.7%
Short Ratio
1.01
Short Shares
1.41

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
$-12.6M
Average Volume
66,468.6x
Bv Per Share
0.72
CAPEX
$-1,853
Ch1m
40.97
Ch1w
-4.09
Ch1y
-62.58
Ch3m
6.84
Ch3y
-70.58
Ch6m
-49.86
Change
1.16%
Change From Open
4.28
Close
6.02
Days Gap
-2.99
Depreciation Amortization
1,912
Dollar Volume
397,603.9
Earnings Date
2026-05-07
Earnings Time
bmo
EBIT
$-12M
EBITDA
$-12M
EPS
$-5.57
F Score
1
FCF
$-11M
FCF EV Yield
-66.65x
FCF Per Share
$-3.56
Financing CF
5,929,046
Fiscal Year End
December
Founded
2,022
Investing CF
-1,853
Ipr
21.8
Iprfo
-92.89
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Last Split Date
2024-08-20
Last Split Type
Reverse
Last10k Filing Date
2026-03-31
Ma150
8.46
Ma150ch
-28.01%
Ma20
5.65
Ma20ch
7.75%
Net CF
-5,027,935
Next Earnings Date
2026-08-10
Open
5.84
Optionable
No
Position In Range
38.46
Post Close
6.09
Postmarket Change Percent
1.97
Postmarket Price
$6.21
Ppne
4,619
Price Date
2026-05-08
Ptbv Ratio
10.43
Relative Volume
0.98x
Share Based Comp
1,643,495
Tr6m
-49.86%
Us State
Florida
Volume
65,288
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does CVKD pay a dividend?

Capital-return profile for this ticker.

Performance

CVKD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-62.6%
S&P 500 1Y: n/a
3Y total return
-70.6%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns CVKD?

Insider, institutional, and short-interest positioning.

Institutional ownership
+6.6%
Float: +83.0% of shares outstanding
Insider ownership
+17.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+1.7%
1.0 days to cover
Y/Y dilution
+51.0%
Negative means the company is buying back shares.
Technical

CVKD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
53.6
Neutral momentum band
Price vs 200-day MA
-35.7%
50/200-day relationship not available
Beta (5Y)
1.83
More volatile than the market
Sharpe ratio
-0.54
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About CVKD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CVKD stock rating?

Cadrenal Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CVKD analysis?

The full report lives at /stocks/CVKD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CVKD?

The latest report frames CVKD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CVKD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.